Pharmaceutical Information - October 7, 2008

Nearly 5,000 Families File Claims Against Autism-Vaccination Link

May 12, 2008 - Topics autism, hospital, genetic, safety and education
Around 5,000 families who believe that a mercury-based preservative, thimerosal, found in many vaccines causes the development of autism have filed claims with the U.S. Court of Claims. The families allege vaccines caused autism and other neurological problems in their children.

Autism is a developmental disability which usually appears in children during their first 36 months. Once an uncommon disorder in the United States, the incidence of autism is now occurring at epidemic rates

read more >>

FDA Issues Alert Over Heparin After Contaminated Stock Found Still In Use

May 9, 2008 - Topics fda, hospital, arthritis, flu and pharmaceutical
The Food and Drug Administration warned the medical community on Friday regarding heparin after learning that some of the facilities still had supplies of the contaminated blood thinner.

A large number of hospitals, medical societies and pharmaceutical organizations were warned despite a recall by the California Department of Health and the FDA's own recall monitoring. Baxter International Inc., the largest supplier of heparin, also showed gaps in the recall response

read more >>

Wal-Mart Brings Down Drug Prices With $10 Plan

May 5, 2008 - Topics senior, prescription, breast cancer, cancer and women
Wal-Mart rolled out on Monday its 90-day special offer to American consumers that sells medicine for $10. The promo includes marked down prices for women's medication and more price cuts on over 1,000 over-the-counter pharmaceuticals.

The $10 drugs cover 350 generic medicines for 90-day prescriptions at Wal-Mart, Neighborhood Market and Sam's Club drugstores across the U.S., except in North Dakota where Wal-Mart has no in-store drugstores. The women's drugs, including treatments for breast cancer and hormone deficiency, are sold at $9. Meanwhile, prices for over 1,000 over-the-counter medication are lowered to $4 or less

read more >>

Federal Agency Approves Use Of Generic Wellbutrin In Depression Patients

April 16, 2008 - Topics wellbutrin, depression, bupropion, pharmaceutical and fda
The U.S. Food and Drug Administration said Wednesday that a generic version of a popular name brand antidepressant is both safe and effective, despite recent consumer complaints

The federal agency reviewed the generic version of Wellbutrin manufactured by Teva after some patients reported their depression returned when they switched from the brand name drug Wellbutrin XL to the generic pharmaceutical. Some patients also complained of headaches, anxiety and other side effects

read more >>

Study Alleges Merck Downplayed Death Risk Of Vioxx

April 15, 2008 - Topics vioxx, study, disease, heart disease and stroke
Drug giant Merck and Co. manipulated data on its withdrawn drug Vioxx, minimized a significantly increased risk of death in patients taking its painkiller and used academic researchers to enhance the credibility of scientific studies largely written by Merck employees.

The allegations come from new research published in the Journal of the American Medical Association. The magazine said Merck offered to pay doctors to sign their names to Vioxx studies ghostwritten by medical publishing companies even if the physicians had little or no involvement in the research

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use